Anika Therapeutics (ANIK) Tops Q2 EPS by 40c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.78 +2.06%
Financial Fact:
Product revenue: 25.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Product revenue: 25.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.42, $0.40 better than the analyst estimate of $0.02. Revenue for the quarter came in at $32.6 million versus the consensus estimate of $29.21 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Jefferies sees metals breakout on currency concerns
- CoVolt Power files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
